This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (24)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DONALD L. HAGER, MD; JAMES N. WILSON, MD

AMA Arch Surg. 1967;94(1):86-89.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE INTRA-ARTERIAL injection of medications in the upper limb may result in serious impairment or loss of part of the extremity. When one reflects on the frequency and casualness with which medications are injected intravascularly into various parts of the upper limb, it is remarkable that there should be so few untoward incidents reported.

The textbooks of pharmacology and anesthesiology comment to a varying degree on the complications associated with the intra-arterial injection of drugs. With the exception of thiopental sodium^1-7 and contrast media, there is little in the medical journals concerning these complications. A number of other compounds have been incriminated; for example, promazine HCl,⁸ chlorpromazine HCl,⁹ ether,¹⁰ and mephenesin (Myanesin).¹¹ A number of reports attribute arterial thrombosis and gangrene to idiosyncrasy or local irritation.^8,9,12,13 It is more likely that these cases reflect the intraarterial injection of the drug.

Reported here are three . . . [Full Text PDF of this Article]

Author Affiliations
LOS ANGELES

From the Orthopaedic Hospital, Los Angeles.

Footnotes
Submitted for publication Aug 13, 1966.

Reprint requests to 326 W 23rd St, Los Angeles 90007 (Dr. Wilson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?